Skip to content

Safety and Efficacy of the Delivery Sheath for Stylet-Driven Leads in Left Bundle Branch Area Pacing

Safety and Efficacy of the Delivery Sheath for Stylet-Driven Leads in Left Bundle Branch Area Pacing

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122158
Enrollment
Unknown
Registered
2026-04-09
Start date
2025-08-05
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmia

Interventions

Experimental group:Use the guide sheath group to assist the active wire driven for pacing in the left bundle branch area

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years; 2. All patients experiencing chronic arrhythmias who are undergoing their first permanent cardiac pacemaker implantation and require ventricular electrode implantation; 3. Willing to participate in the trial and sign the informed consent form; 4. Willing and able to complete all visits at the research centre.

Exclusion criteria

Exclusion criteria: 1. Hypertrophic cardiomyopathy, or interventricular septum thickness >=15mm or <=6mm; 2. Patients with echocardiographic LVEF <50% or systolic heart dysfunction; 3. Patients who have undergone ventricular septal defect closure or repair; 4. Anatomical abnormalities of the superior vena cava pathway; 5. Severe tricuspid valve disease, including severe tricuspid stenosis, severe tricuspid regurgitation, tricuspid valve prolapse, or post-tricuspid valve repair; 6. Severe liver or kidney dysfunction within 14 days prior to surgery; 7. Known or suspected active systemic infection within 14 days prior to surgery; 8. Platelet count <50,000 cells/mm^3 within 14 days prior to surgery; 9. Currently participating in other clinical trials; 10. Expected life expectancy less than one year; 11. Pregnant and/or breastfeeding women, or subjects planning to become pregnant during the study period; 12. Other conditions deemed by the investigator to be unsuitable for participation in the clinical trial.

Design outcomes

Primary

MeasureTime frame
The success rate of transvenous introduction of active electrodes implanted in the left bundle branch region in patients with bradyarrhythmia;

Secondary

MeasureTime frame
Number of attempts and positioning for successful implantation of left bundle branch region electrodes;Left bundle branch region active electrode parameters;Total duration of the surgery, X-ray exposure time and X-ray dose;Time of successful implantation of left bundle branch area electrode, X-ray exposure time and X-ray dose;Cardiac function: ultrasound, NYHA;

Countries

China

Contacts

Public ContactSu Lan

The First Affiliated Hospital of Wenzhou Medical University

sulan@wzhospital.cn+86 137 3874 2616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026